Read + Share
Denkert C, Nekljudova V, Loibl S. HER2-low-positive breast cancer from four neoadjuvant clinical trials - Authors'
reply. Lancet Oncol 2021;22:e427.
PMID: 34592188
|
 |
|
Denkert C, Nekljudova V, Loibl S. HER2-low-positive breast cancer from four neoadjuvant clinical trials - Authors'
reply. Lancet Oncol 2021;22:e427.
PMID: 34592188
|
|
|
|